Name: Pharmacokinetics in Drug Development
ISBN: 978-0-9711767-4-4

Overview

Editors:

Peter L. Bonate,
Danny R. Howard¹

Peter L. Bonate

View editor publications

You can also search for this editor in PubMed Google Scholar
Danny R. Howard
1. Translational Sciences, Novartis Institutes for Biomedical Research, East Hanover, USA
View editor publications

You can also search for this editor in PubMed Google Scholar

Brings together academic science and the practical application of knowledge in drug development

Buy print copy

Hardcover Book USD 219.99

Price excludes VAT (USA)

Tax calculation will be finalised at checkout

About this book

These volumes are designed to be the most complete guide to pharmacokinetics (PK) and its role in drug development. Geared toward graduate level students and scientists in the areas of clinical pharmacology and PK, the volumes will fill a gap between the academic science and the practical application of that knowledge in drug development. Volume 1 discusses the role that PK plays in selected clinical study designs, including first-time-in-man, biopharmaceuticals, and special population studies. Volume 2 details the key regulatory and development paradigms in which PK supplements decision-making during drug development.

Keywords

Analysis
Bonate
Clinical
Design
Development
Drug
Pharmacokinetics
Study

Editors and Affiliations

Translational Sciences, Novartis Institutes for Biomedical Research, East Hanover, USA

Danny R. Howard

Bibliographic Information

Book Title: Pharmacokinetics in Drug Development
Book Subtitle: Clinical Study Design and Analysis (Volume 1)
Editors: Peter L. Bonate, Danny R. Howard
Publisher: American Association of Pharmaceutical Scientists Arlington, VA
Copyright Information: American Association of Pharmaceuticals Scientists 2004
Hardcover ISBN: 978-0-9711767-4-4Published: 05 December 2005
Edition Number: 1
Number of Pages: XII, 628

Publish with us

Policies and ethics

Pharmacokinetics in Drug Development